BENIGN PROSTATE HYPERTROPHY(BPH)
Clinical trials for BENIGN PROSTATE HYPERTROPHY(BPH) explained in plain language.
Never miss a new study
Get alerted when new BENIGN PROSTATE HYPERTROPHY(BPH) trials appear
Sign up with your email to follow new studies for BENIGN PROSTATE HYPERTROPHY(BPH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Which prostate procedure spares your sex life? new study has answers
Symptom relief CompletedThis study looked at 110 men with an enlarged prostate to compare two minimally invasive treatments: laser surgery (HoLEP) and water vapor therapy (Rezum). The goal was to see which one better protects sexual function, especially ejaculation. Participants filled out questionnaire…
Matched conditions: BENIGN PROSTATE HYPERTROPHY(BPH)
Phase: NA • Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
GPS for the prostate: 3D navigation aims to cut surgery risks
Symptom relief CompletedThis study tested a 3D imaging navigation system to help guide HoLEP surgery for benign prostate enlargement. 150 men were split into two groups: one with the navigation system and one without. The goal was to see if the system reduces complications like urine leakage and urethra…
Matched conditions: BENIGN PROSTATE HYPERTROPHY(BPH)
Phase: NA • Sponsor: Chinese PLA General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New laser procedure challenges standard surgery for prostate relief
Symptom relief CompletedThis study tested a new, less invasive laser treatment (TU-FLAP) against standard surgery (TURP) for men with an enlarged prostate causing bothersome symptoms. 56 men were randomly assigned to one of the two procedures and monitored for a year. The goal was to see if the new lase…
Matched conditions: BENIGN PROSTATE HYPERTROPHY(BPH)
Phase: NA • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
New prostate drug tested in healthy men
Knowledge-focused CompletedThis early-stage study tested a new drug called CKD-846 in 31 healthy men to see how the body processes it and if it is safe. The goal was to gather information, not to treat the condition. Participants were healthy men aged 19 to 55 who agreed to use contraception.
Matched conditions: BENIGN PROSTATE HYPERTROPHY(BPH)
Phase: PHASE1 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC